Endometrial cancer and its cell lines.
Cancer cell line
Cell isolation
Cell line
Endometrial cancer
In vitro models
Tissue culture
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
29
07
2019
accepted:
07
12
2019
pubmed:
19
12
2019
medline:
8
10
2020
entrez:
19
12
2019
Statut:
ppublish
Résumé
Endometrial cancer is one of the most common gynaecological malignancies worldwide. One type of research in this field is the growing of cell lines (CLs) and cultures, which can be used to explore the biological mechanisms of cancer. The purpose of this review is to offer an overview of the current literature and highlight the importance of correct CL studies. We carried out a literature analysis of more than 60 articles from the Pubmed, Medline databases that were almost exclusively published in indexed journals in the last 10 years as well as the primary originating scientific studies of specific CLs. We then summarized the newest findings and recommendations. Cell lines are becoming widely used as in vitro tumour models. Recent work has shown inconsistencies in nomenclature and culturing of CLs. Their genomic evolution leads to a high degree of variation across CL strains therefore it is of the utmost importance to recognize the variability within laboratory cancer models. Laboratories must adapt, incorporate additional characterisation techniques and view this situation as an opportunity to improve the reproducibility of pre-clinical cancer research. The authors offer a comprehensive literature review about endometrial cancer CLs, a review of the current literature and advice on culturing CLs.
Identifiants
pubmed: 31848918
doi: 10.1007/s11033-019-05226-3
pii: 10.1007/s11033-019-05226-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1399-1411Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : P3-0036
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : I0-0029
Organisme : Univerzitetni klinicni center Maribor
ID : IRP-2018/01-19
Références
Pathologe. 2016 Nov;37(6):500-511
pubmed: 27738815
Cancer Res. 2014 May 1;74(9):2377-84
pubmed: 24717177
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
pubmed: 25559415
Annu Rev Pathol. 2019 Jan 24;14:339-367
pubmed: 30332563
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8
pubmed: 12824418
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jul;37(7):1103-11
pubmed: 4031568
Acta Obstet Gynaecol Jpn. 1972 Jan;19(1):47-58
pubmed: 4678779
Chem Biol Interact. 2015 Jun 5;234:309-19
pubmed: 25437045
Cytotechnology. 2018 Feb;70(1):339-350
pubmed: 28988392
In Vitro Cell Dev Biol Anim. 1999 Apr;35(4):183-9
pubmed: 10478797
Br J Cancer. 2014 Sep 9;111(6):1021-46
pubmed: 25117809
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Technol Cancer Res Treat. 2010 Apr;9(2):179-89
pubmed: 20218740
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Dis Model Mech. 2018 Nov 16;11(11):
pubmed: 30459183
J Vis Exp. 2018 May 20;(135):
pubmed: 29863662
Cancer Res. 2017 May 15;77(10):2557-2563
pubmed: 28507049
Investig Genet. 2013 Nov 18;4(1):23
pubmed: 24245746
PLoS One. 2013;8(1):e55145
pubmed: 23372829
Nature. 2015 Apr 16;520(7547):307-11
pubmed: 25877200
Lancet. 2016 Mar 12;387(10023):1094-1108
pubmed: 26354523
Gynecol Oncol. 2012 Oct;127(1):241-8
pubmed: 22710073
Oncogene. 2009 Jan 22;28(3):461-8
pubmed: 18978815
Science. 2017 Feb 10;355(6325):584-585
pubmed: 28183939
J Transl Med. 2019 Feb 27;17(1):58
pubmed: 30813939
Gynecol Oncol Res Pract. 2016 Dec 13;3:14
pubmed: 27999680
BMC Cancer. 2012 Oct 06;12:458
pubmed: 23039365
J Biomol Tech. 2018 Jul;29(2):25-38
pubmed: 29805321
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Oncol Rep. 2004 Oct;12(4):701-7
pubmed: 15375488
Gynecol Oncol. 1984 Feb;17(2):213-30
pubmed: 6706226
Clin Chim Acta. 2019 Feb;489:225-232
pubmed: 30107158
Mol Cell. 2018 Oct 4;72(1):162-177.e7
pubmed: 30244833
Ann N Y Acad Sci. 1991;622:402-21
pubmed: 2064198
Breast J. 2020 Feb;26(2):328-330
pubmed: 31749235
Radiol Oncol. 2017 Feb 22;51(1):47-55
pubmed: 28265232
J Biol Chem. 2017 Dec 15;292(50):20592-20598
pubmed: 28974579
Wien Klin Wochenschr. 2015 Dec;127 Suppl 5:S204-9
pubmed: 25821058
PeerJ. 2017 Mar 21;5:e3079
pubmed: 28344902
J Vis Exp. 2014 Jan 28;(83):e50203
pubmed: 24513647
Gynecol Oncol. 1992 Mar;44(3):217-22
pubmed: 1541432
Cancer Res. 2019 Apr 1;79(7):1263-1273
pubmed: 30894373
Science. 2014 Dec 19;346(6216):1452-3
pubmed: 25525228
Nature. 2016 Feb 4;530(7588):57-62
pubmed: 26814967
Genomics. 2016 Jun;107(6):259-66
pubmed: 27107655
J Forensic Sci. 2018 Nov;63(6):1836-1840
pubmed: 29464703
Pathologe. 2019 Feb;40(1):13-20
pubmed: 30707274
J Natl Cancer Inst. 1964 Sep;33:441-56
pubmed: 14207855
BMC Cancer. 2016 Mar 08;16:195
pubmed: 26951071
J Histochem Cytochem. 2011 Jan;59(1):6-12
pubmed: 20852036
Cancer Invest. 1986;4(2):157-84
pubmed: 3518877
Hum Cell. 2002 Sep;15(3):104-17
pubmed: 12703541
PLoS Biol. 2017 Apr 17;15(4):e2001438
pubmed: 28414712
Nature. 2018 Aug;560(7718):325-330
pubmed: 30089904
Database (Oxford). 2018 Jan 1;2018:
pubmed: 29688349
J Cancer Res Clin Oncol. 1994;120(12):712-6
pubmed: 7798295
J Natl Cancer Inst. 2013 Apr 3;105(7):452-8
pubmed: 23434901
Int J Mol Sci. 2018 Aug 09;19(8):
pubmed: 30096949
F1000Res. 2017 Jan 27;6:81
pubmed: 28184290